RESUMO
The relation between serum ferritin levels and stainable-iron deposits in the liver, spleen, and bone marrow was investigated in 36 patients with chronic renal failure who died after being on haemodialysis for 1-103 months. Elemental iron (mean, 5450 mg) had been given intravenously as iron dextran to patients in a long-term subgroup, who had been on dialysis for more than 3 months. The results of semiquantitative histochemical assessment of tissue iron in slides obtained at necropsy (scale 0 to 4+) were confirmed by chemical analyses of tissue iron. Serum ferritin levels correlated well with the degree of hepatosplenic siderosis but did not always correlate with bone-marrow iron stores in these patients. Serum ferritin concentrations were raised in 10 marrow-iron-depleted subjects (mean, 1336 ng/dl). The paradoxical association of hepatosplenic siderosis with marrow iron depletion was observed in most of the patients on dialysis for less than 40 months. The histochemical data show that the bulk of intravenously injected iron dextran is taken up by the liver and spleen; that the hepatosplenic stores fail to be mobilised to the bone marrow; and that intravenous iron-dextran therapy, by-passing the intestinal mechanism for the regulation of iron absorption, carries a high risk of long-term hepatosplenic siderosis.
Assuntos
Medula Óssea/metabolismo , Ferritinas/sangue , Complexo Ferro-Dextran/administração & dosagem , Ferro/metabolismo , Idoso , Feminino , Humanos , Ferro/uso terapêutico , Complexo Ferro-Dextran/farmacologia , Falência Renal Crônica/terapia , Fígado/metabolismo , Hepatopatias/etiologia , Masculino , Pessoa de Meia-Idade , Diálise Renal/efeitos adversos , Siderose/etiologia , Baço/metabolismo , Esplenopatias/etiologiaRESUMO
The distribution of stainable iron stores was investigated in various organs of 50 hemodialysis patients with chronic renal disease. Massive iron deposits were found in the liver and spleen. Among 18 patients with severe hepatosplenic siderosis, iron deposits were abundant in the adrenal glands, lymph nodes, and lungs and were sparse in the heart, kidneys, and pancreas. There was an absence or scarcity of stainable iron in bone marrow of 19 pats. In five of these marrow-iron-depleted patients, serum concentrations of ferritin were high. In long-term hemodialysis patients, a variety of factors make massive iron overloads of various organs a likely occurrence, severe hepatosplenic siderosis may occur in marrow-iron-depleted patients, and serum ferritin levels in this setting may not always accurately reflect the status of marrow iron store.
Assuntos
Hemossiderose/etiologia , Diálise Renal/efeitos adversos , Adulto , Idoso , Anemia Hipocrômica/prevenção & controle , Autopsia , Medula Óssea/metabolismo , Feminino , Ferritinas/sangue , Humanos , Absorção Intestinal , Ferro/metabolismo , Ferro/uso terapêutico , Falência Renal Crônica/terapia , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Baço/metabolismoRESUMO
Acute renal failure and a syndrome characteristic of acute renal vein thrombosis developed in a patient with sickle trait and gram-negative bacteremia. It is suggested that intrarenal vaso-occlusion by sickled erythrocytes produced signs and symptoms typical of renal vein thrombosis and contributed to the severity of the acute renal failure.
